Gene therapy, cell transplantation and stroke

Frontiers in Bioscience

Volumn 11, Issue 1 P.889-1198, 2006, Pages 1090-1100

  Borlongan, Cesario V ^a,b   Fournier, Christina ^a   Stahl, Christine E ^c   Yu, Guolong ^a   Xu, Lin ^a   Matsukawa, Noriyuki ^a   Newman, Mary ^d   Yasuhara, Takao ^a   Hara, Koichi ^a   Hess, David C ^a,b   Sanberg, Paul R ^d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EISENHOWER ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cancer; Gene therapy; Intracerebral Transplantation; Nervous system; Neuron; Neuroprotection; Neuroteratocarcinoma Cells; NT2N; Review; Stroke; Therapeutic; Treatment; Tumor

Indexed keywords

EID: 32844463899     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1865     Document Type: Review

References (80)

1. Trojanowski, J.Q., S.R. Kleppner, R.S. Hartley, M. Miyazono, N.W. Fraser, S. Kesari, and V.M. Lee:. Transfectable and transplantable postmitotic human neurons: a potential "platform" for gene therapy of nervous system diseases. Exp Neurol 144, 92-97 (1997)
2. Borlongan, C.V., P.R. Sanberg, and T.B. Freeman: Neural transplantation for neurodegenerative disorders. Lancet 353, 8129-30 (1999)
3. Nishino, H., and C.V. Borlongan: Restoration of function by neural transplantation in the ischemic brain. Prog Brain Res 127, 461-476 (2000)
4. Johnston, R.E., O. Dillon-Carter, W.J. Freed, and C.V. Borlongan:Trophic factor secreting kidney cell lines: in vitro characterization and functional effects following transplantation in ischemic rats. Brain Res. 900, 268-76 (2001)
5. Alexi, T., C.V. Borlongan, R.L. Faull, C.E. Williams, R.G. Clark, P.D. Gluckman, and P.E. Hughes:. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 60, 409-470 (2000)
6. Freeman, T.B., F. Cicchetti, R.A. Hauser, T.W. Deacon, X.J. Li, S.M. Hersch, G.M. Nauert, P.R. Sanberg, J.H. Kordower, S. Saporta, and O. Isacson: Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci 97, 13877-13882 (2000)
7. Kordower, J.H., and C.E. Sortwell: Neuropathology of fetal nigra transplants for Parkinson's disease. Prog Brain Res 127, 333-344 (2000)
8. Bjorklund, A.: Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2, 683-689 (1992)
9. Mahalik, T.J., W.E. Hahn, G.H. Clayton, and G.P. Owens: Programmed cell death in developing grafts of fetal substantia nigra. Exp Neurol 129, 27-36 (1994)
10. Nikkhah, G., C. Bentlage, M.G. Cunningham, and A. Bjorklund: Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci 14, 3449-3461 (1994)
11. Nikkhah, G., M.G. Cunningham, A. Jodicke, U. Knappe, and A. Bjorklund: Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633, 133-143 (1994)
12. Freed, W.J., A.M. Adinol, J.D. Laskin, and H.M. Geller: Transplantation of B16/C3 melanoma cells into the brains of rats and mice. Brain Res 485, 349-362 (1989)
13. Kawaja, M.D., A.M. Fagan, B.L. Firestein, and F.H. Gage:. Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: an assessment of graft size and ultrastructure. J Comp Neurol 307, 695-706 (1991)
14. Nishino, H., T. Hashitani, and M. Kumazaki: Phenotypic plasticity of grafted catecholaminergic cells in the dopamine-depleted caudate nucleus in the rat. Neurosci Res Suppl 13, S54-60 (1990)
15. Schueler, S.B., J.D. Ortega, J. Sagen, and J.H. Kordower: Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. J Neurosci 13, 4496-4510 (1993)
16. Emerich, D.F., S.R. Winn, L. Christenson, M.A. Palmatier, F.T. Gentile, and P.R. Sanberg: A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy. Neurosci Biobehav Rev 16, 437-447 (1992)
17. Studer, L., V. Tabar, and R.D. McKay: Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1, 290-295 (1998)
18. Svendsen, C.N., M.A. Caldwell, J. Shen, M.G. ter Borg, A.E. Rosser, P. Tyers, S. Karmiol, and S.B. Dunnett: Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol 148, 135-146 (1997)
19. Freund, T.F., J.P. Bolam, A. Bjorklund, U. Steveni, S.B. Dunnett, J.F. Powell, and A.D. Smith: Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochernical study. J Neurosci 5, 603-616 (1985)
20. Mahalik, T.J., T.E. Finger, I. Stromberg, and L. Olson: Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J Comp Neurol 240, 60-70 (1985)
21. Faull, R.L.M., H.J. Waldvogel, L.F.B. Nicholson, M.N. Williams, and M. Dragunow: Huntington's disease and neural transplantation: GABAA receptor changes in the basal ganglia in Huntington's disease, in the human brain and in the quinolinic acid lesioned rat model of the disease following fetal neuron transplants. In: Neurotransmitters in the Human Brain. Ed: Tracey DJ, Plenum Press, NY, 173-197 (1995)
22. Hoffer, B., and L. Olson: Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques. J Neural Transm Suppl 49, 1-10 (1997)
23. Isacson, O., L. Costantini, J.M. Schumacher, F. Cicchetti, S. Chung, and K. Kim: Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells. Parkinsonism Relat Disord 7, 205-212 (2001)
24. Kleppner, S.R., K.A. Robinson, J.Q. Trojanowski, V.M. Lee: Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J Comp Neurol 357, 618-632 (1995)
25. Miyazono, M., V.M. Lee, and J.Q. Trojanowski: Proliferation, cell death, and neuronal differentiation in transplanted human embryonal carcinoma (NTera2) cells depend on the graft site in nude and severe combined immunodeficient mice. Lab Invest 73, 273-283 (1995)
26. Miyazono, M., P.C. Nowell, J.L. Finan, V.M. Lee, and J.Q. Trojanowski: Long-term integration and neuronal differentiation of human embryonal carcinoma cells (NTera-2) transplanted into the caudoputamen of nude mice. J Comp Neurol 376, 603-613 (1996)
27. Pleasure, S.J., C. Page, and V.M. Lee: Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12, 1802-1815 (1992)
28. Pleasure, S.J., and V.M. Lee: NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 35, 585-602 (1993)
29. Lee, V.M., and P.W. Andrews: Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J Neurosci 6, 514-521 (1986)
30. Lee, V.M., R.S. Hartley, and J.Q. Trojanowski: Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury. Prog Brain Res 128, 299-307 (2000)
31. Zetterstrom, R.H., A. Simon, M.M. Giacobini, U. Eriksson, and L. Olson: Localization of cellular retinoid-binding proteins suggests specific roles for rerinoids in the adult central nervous system. Neuroscience 62, 899-918 (1994)
32. Faiella, A., V. Zappavigna, F. Mavilio, and E. Boncinelli: Inhibition of retinoic acid-induced activation of 3′ human HOXB genes by antisense oligonucleotides affects sequential activation of genes located upstream in aie four HOX clusters. Proc Natl Acad Sci 91, 5335-5339 (1994)
33. Faiella, A., M. Wernig, G.G. Consalez, U. Hostick, C. Hofmann, E. Hustert, E. Boncinelli, R. Balling, and J.H. Nadeau: A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 9, 227-236 (2000)
34. Saporta, S., C.V. Borlongan, and P.R. Sanberg: Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience 91, 519-525 (1999)
35. Zigova, T., L.F. Barroso, A.E. Willing, S. Saporta, M.P. McGrogan, T.B. Freeman, and P.R. Sanberg: Dopaminergic phenotype of hNT cells in vitro. Brain Res Dev Brain Res 122, 87-90 (2000)
36. Matsuoka, T., T. Kondoh, N. Tamaki, T. Nishizaki: The GABAA receptor is expressed in human neurons derived from a teratocarcinoma cell line. Biochem Biophys Res Commun 237, 719-23 (1997)
37. Flax, J.D., S. Aurora, C. Yang, C. Simonin, A.M. Wills, L.L. Billinghurst, M. Jendoubi, R.L. Sidman, J.H. Wolfe, S.U. Kim, and E. Y. Snyder: Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16, 1033-1039 (1998)
38. Borlongan, C.V., Y. Tajima, J.Q. Trojanowski, V.M. Lee, P.R. Sanberg: Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149, 310-321 (1998)
39. Borlongan, C.V., Y. Tajima, J.Q. Trojanowski, V.M. Lee, and P.R. Sanberg: Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line. Neuroreport 9, 3703-3709 (1998)
40. Borlongan, C.V., S. Saporta, S.G. Poulos, A. Othberg, and P.R. Sanberg: Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. Neuroreport 9, 2837-2842 (1998)
41. Borlongan, C.V.: Transplantation therapy for Parkinson's disease. Expert Opin Investig Drugs 9, 2319-2330 (2000)
42. Chang, C.F., M. Morales, J. Chou, H.L. Chen, B. Hoffer, and Y. Wang. Bone morphogenetic proteins are involved in fetal kidney tissue transplantation- induced neuroprotection in stroke rats. Neuropharmacology 43, 418-426 (2002)
43. Carroll, J.E., D.C. Hess, E.F. Howard, and W.D. Hill: Is nuclear factor-kappaB a good treatment target in brain ischemia/reperfusion injury? Neuroreport 11, 1-4 (2000)
44. Hill, W.D., D.C. Hess, J.E. Carroll, C.G. Wakade, E.F. Howard, Q. Chen, C. Cheng, A. Martin-Studdard, J.L. Waller, and R.A. Beswick: The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res Bull 55, 375-386 (2001)
45. Mahmood, A., D. Lu, L. Wang, Y. Li, M. Lu, and M. Chopp: Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 49, 1196-203 (2001)
46. Li, Y., J. Chen, and M. Chopp: Cell proliferation and differentiation from ependymal, subependymal and choroid plexus cells in response to stroke in rats. J Neurol Sci 193, 137-46 (2002)
47. Chen, J., Y. Li, L. Wang, Z. Zhang, D. Lu, M. Lu, and M. Chopp: Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-11 (2001)
48. Trojanowski, J.Q., J.R. Mantione, J.H. Lee, D.P. Seid, T. You, L.J. Inge, V.M.-Y. Lee:. Neurons derived from a teratocarcinoma cell line establish molecular and structural polarity following transplantation into the rodent brain. Exp Neurol 122, 283-294 (1993)
49. Henderson, B.T.H., C.G. Clough, R.C. Hughes, E.R. Hitchcock, B.G. Kenny: Implantation of human ventral mesencephalon to the right caudate nucleus in ad-vanced Parkinson's disease. Arch Neurol 48, 822-827 (1991)
50. Freed, C.R., R.E. Breeze, N.L. Rosenberg, S.A. Schneck, E. Kriek, J.-X. Qi, T. Lone, Y. Zhang, J.A. Snyder, T.H. Wells, L.O. Ramig, L. Thompson, J.C. Mazziotta, S.C. Huang, S.T. Grafton, D. Brooks, G. Sawle, G. Schroter, and A.A. Ansari: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327, 1549-1555 (1992)
51. Samacki, P.G., R.W. Engelman, Y. Chang, N.K. Day, R.A. Good, and P.R. Sanberg: Immunosuppression by hNT neurons and supernatant. Exp Neurol 153, 386 (1998)
52. Connor, B., and M. Dragunow: The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Reviews 27, 1-39 (1998)
53. Hughes, P.E., T. Alexi, M. Walton, E. Williams, M. Dragunow, R.G. Clark, and P.D. Gluckman: Activity and injury-dependent expression of inducible transcription factors, growth factors, and apoptosis-related genes within the central nervous system. Prog Neurobiol 57, 421-450 (1999)
54. Tomac, A.C., A. Grinberg, S.P. Huang, C. Nosrat, Y. Wang, C.V. Borlongan, S.Z. Lin, Y.H. Chiang, L. Olson, H. Westphal, and B.J. Hoffer: Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience 95, 1011-1023 (2000)
55. Chiang, Y.H., S.Z. Lin, C.V. Borlongan, B.J. Hoffer, M. Morales, and Y. Wang: Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation. J Cereb Blood Flow Metab 19, 1329-1335 (1999)
56. Tornatore, C., B. Baker-Cairns, G. Yadid, R. Hamilton, and K. Meyers: Expression of tyrosien hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum. Cell Transplant 5, 145-163 (1996)
57. Lin, S.Z., Y. Wang, B.J. Hoffer, P.R. Sanberg, and C.V. Borlongan: Transplantation of hNT cells in adult rats with cortical stroke. Soc Neurosci Abstr 25, 1344 (1999)
58. Schinstine, M., N.D. Stall, and L. Iacovitti: Induction of tyrosine hydroxylase in hNT neurons. Soc Neurosci Abstr 22, 1959 (1996)
59. Iacovitti, L., and N.D. Stall: Expression of tyrosine hydroxylase in newly differentiated neurons from a human cell line (hNT) Neuroreport 8, 1471-1474 (1997)
60. Zigova, T., A.E. Willing, E.M. Tedesco, C.V. Borlongan, S. Saporta, G.L. Snable, and P.R. Sanberg: Lithium chloride induces the expression of tyrosine hydroxylase in hNT neurons. Exp Neurol 157, 251-258 (1999)
61. Hurlbert, M.S., R.I. Gianani, C. Hutt, C.R. Freed, and F.G. Kaddis: Neural transplantation of hNT neurons for Huntington's disease. Cell Transplant 8, 143-151 (1999)
62. Kondziolka, D., L. Wechsler, S. Goldstein, C. Meltzer, K.R. Thulborn, J. Gebel, P. Jannetta, S. DeCesare, E.M. Elder, M. McGrogan, M.A. Reitman, and L. Bynum: Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55, 565-569 (2000)
63. Trojanowski, J.Q., S.R. Kleppner, R.S. Hartley, M. Miyazono, N.W. Fraser, S. Kesari, and V.M. Lee:. Transfectable and transplantable postmitotic human neurons: a potential "platform" for gene therapy of nervous system diseases. Exp Neurol 144, 92-97 (1997)
64. Meltzer, C.C., D. Kondziolka, V.L. Villemagne, L. Wechsler, S. Goldstein, K.R. Thulborn, J. Gebel, E.M. Elder, S. DeCesare, and A. Jacobs:. Serial {18F} fluorcdeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery 49, 586-592 (2001)
65. Nelson, P.T., D. Kondziolka, L. Wechsler, S. Goldstein, J. Gebel, S. DeCesare, E.M. Elder, P.J. Zhang, A. Jacobs, M. McGrogan, V.M.-Y. Lee, and J.Q. Trojanowski: Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Path 160, 1201-1206 (2002)
66. Brundin, P., S. Dunnett, A. Bjorklund, and G. Nikkhah: Transplanted dopaminergic neurons: more or less? Nat Med 7, 512-513 (2001)
67. Zivin, J.A. Cell transplant therapy for stroke: Hope or hype. Neurology 55, 467 (2000)
68. Gortz, P., W. Fleischer, C. Rosenbaum, F. Otto, and M. Siebler: Neuronal network properties of human teratocarcinoma cell line-derived neurons. Brain Res 1018, 18-25 (2004)
69. Watson, D.J., L. Longhi, E.B. Lee, C.T. Fulp, S. Fujimoto, N.C. Royo, M.A. Passini, J.Q. Trojanowski, V.M. Lee, T.K. McIntosh, and J.H. Wolfe: Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury. J Neuropathol Exp Neurol 62, 368-380 (2003)
70. Willing, A.E., T. Zigova, M. Milliken, S. Poulos, S. Saporta, M. McGrogan, G. Snable, and P.R. Sanberg: Lithium exposure enhances survival of NT2N cells (hNT neurons) in the hemiparkinsonian rat. Eur J Neurosci 16, 2271-2278 (2002)
71. Misiuta, I.E., L. Anderson, M.P. McGrogan, P.R. Sanberg, A.E. Willing, and T. Zigova: The transcription factor Nurr1 in human NT2 cells and hNT neurons. Brain Res Dev Brain Res 145, 107-115 (2003)
72. Christie, S.D., D. Sadi, and I. Mendez: Intraspinal transplantation of hNT neurons in the lesioned adult rat spinal cord. Can J Neurol Sci 31, 87-96 (2004)
73. Saporta, S., A.S. Makoui, A.E. Willing, M. Daadi, D.W. Cahill, and P.R. Sanberg:. Functional recovery after complete contusion injury to the spinal cord and transplantation of human neuroteratocarcinoma neurons in rats. J Neurosurg 9763-68 (2002)
74. Longhi, L., D.J. Watson, K.E. Saatman, H.J. Thompson, C. Zhang, S. Fujimoto, N. Royo, D. Castelbuono, R. Raghupathi, J.Q. Trojanowski, V.M. Lee, J.H. Wolfe, N. Stocchetti, and T.K. McIntosh: Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma 21, 1723-736 (2004)
75. Kofler, P., B. Wiesenhofer, C. Rehrl, G. Baier, G. Stockhammer, and C. Humpel: Liposome-mediated gene transfer into established CNS cell lines, primary glial cells, and in vivo. Cell Transplant 7, 175-85 (1998)
76. Mukhtar, M., H. Duke, M. BouHamdan, and R.J. Pomerantz: Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir. Hum Gene Ther 11, 347-59 (2000)
77. Cao, Y.J., T. Shibata, and N.G. Rainov: Hypoxia-inducible transgene expression in differentiated human NT2N neurons-a cell culture model for gene therapy of postischemic neuronal loss. Gene Ther 8(17), 1357-62 (2001)
78. Schmeisser, F., M. Donohue, and J.P. Weir:. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors. Hum Gene Ther 13, 2113-24 (2002)
79. Cordelier, P., E. Van Bockstaele, S.A. Calarota, and D.S. Strayer: Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. Mol Ther 7(6), 801-10 (2003)
80. Huang, D., A. Desbois, G. Chen, H. Fang, and S.T. Hou: Characterization of the expression of key adenoviral receptors CAR and integrin beta3/beta5 subunits on the membrane of human NT2 neurons. J Mol Neurosci 24, 323-8 (2004)